CONDENSED CONSOLIDATING BALANCE SHEET AND STATEMENT OF OPERATIONS (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Total Current Assets	$ 761,404	$ 725,235
Investment in subsidiaries and variable interest entity (VIE)	0
Intercompany receivables	0
Other assets	967,178
Total Assets	1,728,582	1,667,269
Total Current Liabilities	3,952,458	3,395,445
Intercompany payables	0
Other liabilities	197,202
Total Liabilities	4,149,660	3,510,972
Capital stock and additional paid in capital	3,109,303
Accumulated deficit	(5,790,315)	(4,885,509)
Accumulated other comprehensive income (loss)	157,531	(13,204)
Non-controlling interests	102,403
Total Deficit	(2,421,078)
Total Liabilities and Shareholders' Equity	1,728,582	$ 1,667,269
Yubo International Biotech Limited
Total Current Assets	0
Investment in subsidiaries and variable interest entity (VIE)	2,421,078
Intercompany receivables	0
Other assets	0
Total Assets	2,421,078
Total Current Liabilities	0
Intercompany payables	0
Other liabilities	0
Total Liabilities	0
Capital stock and additional paid in capital	0
Accumulated deficit	(2,421,078)
Accumulated other comprehensive income (loss)	0
Non-controlling interests	0
Total Deficit	(2,421,078)
Total Liabilities and Shareholders' Equity	2,421,078
Platinum (Cayman Islands) and Limited Platinum HK
Total Current Assets	0
Investment in subsidiaries and variable interest entity (VIE)	930,000
Intercompany receivables	0
Other assets	0
Total Assets	930,000
Total Current Liabilities	150,000
Intercompany payables	0
Other liabilities	0
Total Liabilities	150,000
Capital stock and additional paid in capital	1,569,229
Accumulated deficit	(789,229)
Accumulated other comprehensive income (loss)	0
Non-controlling interests	0
Total Deficit	780,000
Total Liabilities and Shareholders' Equity	930,000
YuboGlobal
Total Current Assets	76,098
Investment in subsidiaries and variable interest entity (VIE)	0
Intercompany receivables	430,590
Other assets	21,232
Total Assets	527,920
Total Current Liabilities	76,772
Intercompany payables	43,358
Other liabilities	0
Total Liabilities	120,130
Capital stock and additional paid in capital	823,897
Accumulated deficit	(416,107)
Accumulated other comprehensive income (loss)	0
Non-controlling interests	0
Total Deficit	407,790
Total Liabilities and Shareholders' Equity	527,920
Yubo Chengdu (WFOE)
Total Current Assets	0
Investment in subsidiaries and variable interest entity (VIE)	0
Intercompany receivables	0
Other assets	0
Total Assets	0
Total Current Liabilities	0
Intercompany payables	0
Other liabilities	0
Total Liabilities	0
Capital stock and additional paid in capital	0
Accumulated deficit	0
Accumulated other comprehensive income (loss)	0
Non-controlling interests	0
Total Deficit	0
Total Liabilities and Shareholders' Equity	0
Eliminations
Total Current Assets	0
Investment in subsidiaries and variable interest entity (VIE)	1,491,078
Intercompany receivables	982,704
Other assets	0
Total Assets	508,374
Total Current Liabilities	0
Intercompany payables	988,575
Other liabilities	0
Total Liabilities	988,575
Capital stock and additional paid in capital	(928,673)
Accumulated deficit	2,425,622
Accumulated other comprehensive income (loss)	0
Non-controlling interests	0
Total Deficit	1,496,949
Total Liabilities and Shareholders' Equity	508,374
Yubo Beijing (VIE) and Subsidiaries
Total Current Assets	685,306
Investment in subsidiaries and variable interest entity (VIE)	0
Intercompany receivables	552,114
Other assets	945,946
Total Assets	2,183,366
Total Current Liabilities	3,725,686
Intercompany payables	945,217
Other liabilities	197,202
Total Liabilities	4,868,105
Capital stock and additional paid in capital	1,644,850
Accumulated deficit	(4,589,523)
Accumulated other comprehensive income (loss)	157,531
Non-controlling interests	102,403
Total Deficit	(2,684,739)
Total Liabilities and Shareholders' Equity	$ 2,183,366